New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
Anthony D D’Urzo,1 Mario Cazzola,2 Nicola A Hanania,3 Roland Buhl,4 M Reza Maleki-Yazdi5 1Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; 2Department of Experimental Medicine and Surgery, Tor Vergata University of Rome, Rome, I...
Main Authors: | D'Urzo AD, Cazzola M, Hanania NA, Buhl R, Maleki-Yazdi MR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/new-developments-in-optimizing-bronchodilator-treatment-of-copd-a-focu-peer-reviewed-article-COPD |
Similar Items
-
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
by: Chen R, et al.
Published: (2020-01-01) -
Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01) -
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
by: Singh D, et al.
Published: (2019-12-01) -
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
by: Sethi S, et al.
Published: (2019-03-01) -
Long-acting Bronchodilators in COPD Management: One or Two?
by: Konstantinos Kostikas, et al.
Published: (2023-01-01)